-
1
-
-
84859128633
-
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
-
Rein DB, Stevens GA, Theaker J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55:988-97.
-
(2012)
Hepatology
, vol.55
, pp. 988-997
-
-
Rein, D.B.1
Stevens, G.A.2
Theaker, J.3
-
2
-
-
84866741989
-
Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience
-
Hoerning A, Hegen B, Wingen AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience. Pediatr Transplant 2012;16:742-7.
-
(2012)
Pediatr Transplant
, vol.16
, pp. 742-747
-
-
Hoerning, A.1
Hegen, B.2
Wingen, A.M.3
-
3
-
-
2942587050
-
Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan
-
Matubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934-40.
-
(2004)
Transfusion
, vol.44
, pp. 934-940
-
-
Matubayashi, K.1
Nagaoka, Y.2
Sakata, H.3
-
4
-
-
84891830498
-
Chronic hepatitis E: A review of the literature
-
Fujiwara S, Yokokawa Y, Morino K, et al. Chronic hepatitis E: a review of the literature. J Viral Hepat 2014;21:78-89.
-
(2014)
J Viral Hepat
, vol.21
, pp. 78-89
-
-
Fujiwara, S.1
Yokokawa, Y.2
Morino, K.3
-
6
-
-
84904410410
-
Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity
-
Zhang J, Zhang XF, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2014;20:O397-405.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. O397-O405
-
-
Zhang, J.1
Zhang, X.F.2
Zhou, C.3
-
7
-
-
78049469347
-
Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection
-
Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010;139:1612-8.
-
(2010)
Gastroenterology
, vol.139
, pp. 1612-1618
-
-
Kamar, N.1
Rostaing, L.2
Abravanel, F.3
-
8
-
-
84860303900
-
Pathogenesis and treatment of hepatitis E virus Infection
-
Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus Infection. Gastroenterology 2012;142:1388-97.e1.
-
(2012)
Gastroenterology
, vol.142
, pp. 1388e1-1397e1
-
-
Wedemeyer, H.1
Pischke, S.2
Manns, M.P.3
-
9
-
-
33847358278
-
Safety and efficacy of a recombinant hepatitis E vaccine
-
Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.
-
(2007)
N Engl J Med
, vol.356
, pp. 895-903
-
-
Shrestha, M.P.1
Scott, R.M.2
Joshi, D.M.3
-
10
-
-
84865791569
-
Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: A preliminary report
-
Goyal R, Kumar A, Panda SK, et al. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. AntivirTher 2012;17:1091-6.
-
(2012)
AntivirTher
, vol.17
, pp. 1091-1096
-
-
Goyal, R.1
Kumar, A.2
Panda, S.K.3
|